Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test

Table 1

Characteristics of individuals examined by the ColoDefense assay.

	CRC	NED
Age (years)
Min–Max	25-89	19-60
Median	62	32
Serum volume (mL)
Min–Max	0.5-3.5	0.7-3.5
Median	1.8	1.8

CRC: colorectal cancer; NED: no evidence of diseases.